Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Cortical Excitability Modulation in Major Depressive Disorder

NCT05441969 is registered in ClinicalTrials.gov with Fundacao Champalimaud as lead sponsor.

NCT NCT05441969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05441969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Cortical Excitability Modulation in Major Depressive Disorder
Lead sponsor
Fundacao Champalimaud
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2020
Completion date
December 31, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder